Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Risk of Progression Independent of Relapse Activity and Disability Accumulation in a Real-world Cohort of Multiple Sclerosis Patients Initiated on High-efficacy Versus Low-efficacy Disease Modifying Therapy

Food Effect Study of Fosigotifator, an eIF2B Activator being developed as a Potential Treatment for Amyotrophic Lateral Sclerosis, Vanishing White Matter Disease, and Major Depressive Disorder

National Trends of Motor Neuron Disease associated Age-Adjusted Mortality Rates (AAMRs) from 1999-2020: A CDC Wonder Database Analysis.